ProKidney (NASDAQ:PROK – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03), Zacks reports. The business had revenue of $0.08 million for the quarter.
ProKidney Stock Up 5.7 %
ProKidney stock opened at $1.04 on Tuesday. ProKidney has a 52-week low of $0.94 and a 52-week high of $4.44. The company has a market cap of $303.33 million, a price-to-earnings ratio of -1.89 and a beta of 1.38. The firm’s fifty day moving average is $1.48 and its 200 day moving average is $1.77.
ProKidney Company Profile
Featured Stories
- Five stocks we like better than ProKidney
- How to Invest in Blue Chip Stocks
- Is Intuitive Machines a Buy After Athena’s Disappointing Landing?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Joby Aviation Stock: Virgin Atlantic Deal Signals Big Potential
- What Makes a Stock a Good Dividend Stock?
- Kohl’s Posts Another Kitchen Sink Quarter, But New CEO Has a Plan
Receive News & Ratings for ProKidney Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProKidney and related companies with MarketBeat.com's FREE daily email newsletter.